Current Role of Dacomitinib in Head and Neck Cancer.

about

Current Role of Dacomitinib in Head and Neck Cancer.

Item

http://www.wikidata.org/entity/Q38806115

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Current Role of Dacomitinib in Head and Neck Cancer.

@en

type

Item

label

Current Role of Dacomitinib in Head and Neck Cancer.

@en

prefLabel

Current Role of Dacomitinib in Head and Neck Cancer.

@en

P1476

Current Role of Dacomitinib in Head and Neck Cancer.

@en

P2093

Mahmut Ozsahin

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin

Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.

Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Cancer statistics, 2015

P304

735-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2016.1177022

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Olgun Elicin

P577

2016-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27070370

http://www.w3.org/2001/XMLSchema#string

P921

dacomitinib

Current Role of Dacomitinib in Head and Neck Cancer.

about

Current Role of Dacomitinib in Head and Neck Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921